Free long-acting injectables for patients with psychosis: A step forward

被引：1
|
作者：
Kong, Ling-zhuo [1 ]
Shen, Yu-ting [1 ]
Zhang, Dan-hua [1 ]
Lai, Jian-bo [1 ,2 ,3 ,4 ,5 ,6 ]
Hu, Shao-hua [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Dept Psychiat, Sch Med, Hangzhou 310003, Peoples R China
[2] Key Lab Mental Disorders Management, Hangzhou 310003, Zhejiang, Peoples R China
[3] Brain Res Inst Zhejiang Univ, Hangzhou 310003, Peoples R China
[4] Zhejiang Engn Ctr Math Mental Hlth, Hangzhou 310003, Peoples R China
[5] Zhejiang Univ, NHC & CAMS Key Lab Med Neurobiol, Sch Brain Sci & Brian Med, Dept Neurobiol,Sch Med, Hangzhou 310003, Peoples R China
[6] Zhejiang Univ, MOE Frontier Sci Ctr Brain Sci & Brain machine Int, Sch Med, Hangzhou 310003, Peoples R China
来源：
ASIAN JOURNAL OF PSYCHIATRY | 2023年 / 83卷
关键词：
Long-acting injectable; Psychosis; Free; PREVALENCE;
D O I：
10.1016/j.ajp.2023.103476
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Machine learning models to accelerate the design of polymeric long-acting injectables
    Bannigan, Pauric
    Bao, Zeqing
    Hickman, Riley J.
    Aldeghi, Matteo
    Hase, Florian
    Aspuru-Guzik, Alan
    Allen, Christine
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [32] Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics
    Jörg Mahlich
    Kerstin Olbrich
    Adrian Wilk
    Antonie Wimmer
    Claus Wolff-Menzler
    Clinical Drug Investigation, 2021, 41 : 99 - 113
  • [33] Hospital Readmission Rates Among Patients With Schizophrenia Treated With Long-Acting Injectables or Oral Antipsychotics
    MacEwan, Joanna P.
    Kamat, Siddhesh A.
    Duffy, Ruth A.
    Seabury, Seth
    Chou, Jacquelyn W.
    Legacy, Susan N.
    Hartry, Ann
    Eramo, Anna
    Karson, Craig
    PSYCHIATRIC SERVICES, 2016, 67 (11) : 1183 - 1188
  • [34] Long-Acting Injectables and Risk for Rehospitalization Among Patients With Schizophrenia in the Home Care Program in Taiwan
    Ju, Po-Chung
    Chou, Frank Huang-Chih
    Lai, Te-Jen
    Chuang, Po-Ya
    Lin, Yung-Jung
    Yang, Ching-Wen Wendy
    Tang, Chao-Hsiun
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (01) : 23 - 29
  • [35] A Step Forward for Long-Acting PCSK9 Inhibition Improvements Without a Breakthrough
    Santos, Raul D.
    Nasir, Khurram
    Shapiro, Michael D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (20) : 2048 - 2050
  • [36] IMPACT OF INITIATING LONG-ACTING INJECTABLES ON ALL -CAUSE AND PSYCHIATRIC HOSPITALIZATION IN PATIENTS WITH BIPOLAR I DISORDER
    Greene, M.
    Yan, T.
    Chang, E.
    Touya, M.
    VALUE IN HEALTH, 2018, 21 : S189 - S189
  • [37] Cardiovascular risk factors and metabolic syndrome in patients treated with long-acting injectables antipsychotics: a retrospective study
    De Carlo, Vera
    Grancini, Benedetta
    Cassina, Niccolo
    Casati, Lorenzo
    Piccoli, Eleonora
    Vismara, Matteo
    Gobbo, Dario
    Zanaschi, Raffaella
    Lupo, Susanna
    Olivieri, Silvia
    Dell'Osso, Bernardo
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2023, 38 (03) : 160 - 168
  • [38] Diffusion dimensionality modeling of subcutaneous/intramuscular absorption of antibodies and long-acting injectables
    Murali Ramanathan
    Wojciech Krzyzanski
    Journal of Pharmacokinetics and Pharmacodynamics, 2025, 52 (3)
  • [39] Atypical long-acting injectables decrease mortality risk compared to other antipsychotics
    Zagozdzon, P.
    Grabowski, J.
    EUROPEAN PSYCHIATRY, 2019, 56 : S570 - S571
  • [40] The concurrent use of two long-acting injectables in the maintenance treatment of bipolar disorder
    Koh, Li-Ying Charlotte
    Chandwani, Nisha
    Lim, Shuli
    Chan, Christopher Yi Wen
    BIPOLAR DISORDERS, 2021, 23 (03) : 312 - 314
12345